Fundraising FoxSynGen
Sacramento, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into SynGen
Sign up to see every warm intro you have to SynGen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SynGen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SynGen was founded in 2012 by George Barry and Philip H. Coelho.
GB
George BarryCo-Founder of Issuer
PH
Philip H. CoelhoChief Technology Officer and Co-Founder of Issuer
CN
Chuck NovakVice President and Chief Financial Officer of the Issuer
WG
William GerberChief Executive Officer and President of Issuer
Board
CG
WA
Woodrow A. Myers, Jr.Board director
VS
Vic SchmittBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.2M disclosed across 11 of 12 rounds · 2013–2017
▶$400KraisedJun 2017 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedJun 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vic SchmittDirector
- Philip H. CoelhoExecutive Officer
- Chuck NovakExecutive Officer
- George BarryDirector
- Carl GoldfischerDirector
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedApr 2017 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William GerberExecutive Officer, Director
- George BarryDirector
- Philip H. CoelhoExecutive Officer
- Woodrow A. Myers, Jr.Director
- Carl GoldfischerDirector
- Chuck NovakExecutive Officer
- Vic SchmittDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedMar 2017 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Woodrow A. Myers, Jr.Director
- Philip H. CoelhoExecutive Officer
- Carl GoldfischerDirector
- Chuck NovakExecutive Officer
- William GerberExecutive Officer, Director
- Vic SchmittDirector
- George BarryDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedFeb 2017 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedFeb 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chuck NovakExecutive Officer
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Carl GoldfischerDirector
- Vic SchmittDirector
- George BarryDirector
- Philip H. CoelhoExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedJan 2017 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedJan 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Woodrow A. Myers, Jr.Director
- William GerberExecutive Officer, Director
- Philip H. CoelhoExecutive Officer
- George BarryDirector
- Carl GoldfischerDirector
- Vic SchmittDirector
- Chuck NovakExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1MraisedNov 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedNov 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip H. CoelhoExecutive Officer
- Carl GoldfischerDirector
- George BarryDirector
- Vic SchmittDirector
- Chuck NovakExecutive Officer
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1MraisedJul 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl GoldfischerDirector
- Vic SchmittDirector
- Chuck NovakExecutive Officer
- Philip H. CoelhoExecutive Officer
- George BarryDirector
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.6MraisedMay 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chuck NovakExecutive Officer
- George BarryDirector
- Vic SchmittDirector
- Carl GoldfischerDirector
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Philip H. CoelhoExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded SynGen?
- SynGen was founded by George Barry, Philip H. Coelho in 2012.
- Who are SynGen's investors?
- SynGen's investors include Bay City Capital.
- How much funding has SynGen raised?
- SynGen has disclosed $12.2M raised across 11 of its 12 known rounds.
- Where is SynGen headquartered?
- SynGen is headquartered in Sacramento, US.